JP2015536337A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015536337A5 JP2015536337A5 JP2015540784A JP2015540784A JP2015536337A5 JP 2015536337 A5 JP2015536337 A5 JP 2015536337A5 JP 2015540784 A JP2015540784 A JP 2015540784A JP 2015540784 A JP2015540784 A JP 2015540784A JP 2015536337 A5 JP2015536337 A5 JP 2015536337A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- nucleic acid
- acid molecule
- erfe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261721322P | 2012-11-01 | 2012-11-01 | |
| US61/721,322 | 2012-11-01 | ||
| PCT/US2013/067771 WO2014071015A1 (en) | 2012-11-01 | 2013-10-31 | Erythroferrone and erfe polypeptides and methods of regulating iron metabolism |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015536337A JP2015536337A (ja) | 2015-12-21 |
| JP2015536337A5 true JP2015536337A5 (https=) | 2016-12-22 |
| JP6501362B2 JP6501362B2 (ja) | 2019-04-17 |
Family
ID=50628048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015540784A Expired - Fee Related JP6501362B2 (ja) | 2012-11-01 | 2013-10-31 | エリスロフェロンおよびｅｒｆｅポリペプチドならびに鉄代謝を調節する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20160122409A1 (https=) |
| EP (1) | EP2914619B1 (https=) |
| JP (1) | JP6501362B2 (https=) |
| KR (1) | KR102186218B1 (https=) |
| CN (1) | CN104854130A (https=) |
| AU (1) | AU2013337808B2 (https=) |
| BR (1) | BR112015009954A2 (https=) |
| CA (1) | CA2890040A1 (https=) |
| ES (1) | ES2731609T3 (https=) |
| RU (1) | RU2684216C2 (https=) |
| WO (1) | WO2014071015A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109414468B (zh) * | 2016-04-27 | 2021-09-10 | 弗拉基米尔·巴德玛耶夫 | 利用姜烯酚维持体内铁质平衡的方法 |
| WO2018027184A1 (en) * | 2016-08-05 | 2018-02-08 | Silarus Therapeutics, Inc. | Erfe specific antibodies compositions and methods of use |
| US20200040054A1 (en) * | 2016-10-03 | 2020-02-06 | Silarus Therapeutics, Inc. | Erfe fusion polypeptides compositions and methods of use |
| CN110636857B (zh) * | 2017-03-13 | 2024-04-30 | 因全惜客生命科学有限公司 | 人红富铁激素的抗体及其用途 |
| CA3063100A1 (en) * | 2017-05-16 | 2018-11-22 | Generos Biopharma Ltd. | Compositions and methods for treating rheumatoid arthritis |
| EP3634477A4 (en) * | 2017-06-06 | 2021-03-03 | The Regents of the University of California | IMMUNOLOGICAL DOSAGE FOR HUMAN ERYTHROFERRONE |
| WO2019148186A1 (en) * | 2018-01-29 | 2019-08-01 | Silarus Therapeutics, Inc. | Antibodies binding erfe and methods of use |
| WO2019212364A1 (en) * | 2018-05-01 | 2019-11-07 | Christopher Joseph Pemberton | Test for heart failure |
| CA3045370A1 (en) * | 2018-06-08 | 2019-12-08 | Pfizer Inc. | Methods of treating metabolic disease |
| JP2022522265A (ja) * | 2019-01-16 | 2022-04-15 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | エリスロフェロンの変異体及びその使用 |
| CN114761013A (zh) | 2019-09-27 | 2022-07-15 | 迪斯克医药公司 | 治疗骨髓纤维化和相关病症的方法 |
| US12508262B2 (en) | 2020-04-30 | 2025-12-30 | Keros Therapeutics, Inc. | Methods of using ALK2 inhibitors |
| WO2021231798A1 (en) | 2020-05-13 | 2021-11-18 | Disc Medicine, Inc. | Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis |
| WO2022098812A1 (en) | 2020-11-04 | 2022-05-12 | Keros Therapeutics, Inc. | Methods of treating iron overload |
| JP2026506602A (ja) | 2023-02-13 | 2026-02-25 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 鉄過剰関連疾患の処置方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2506668C (en) * | 2002-11-19 | 2014-08-19 | Drg International, Inc. | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| GB0423973D0 (en) * | 2004-10-28 | 2004-12-01 | Ares Trading Sa | C1q related points |
| US7968091B2 (en) * | 2005-02-16 | 2011-06-28 | The General Hospital Corporation | Methods and compositions to regulate iron metabolism |
| TW201307390A (zh) * | 2007-02-02 | 2013-02-16 | Amgen Inc | 海帕西啶（ｈｅｐｃｉｄｉｎ）、海帕西啶拮抗劑及使用方法 |
| GB0818273D0 (en) * | 2008-10-06 | 2008-11-12 | Cambridge Entpr Ltd | Modulation of cellular activity and differentiation |
| CN102245626A (zh) * | 2008-12-05 | 2011-11-16 | 加利福尼亚大学董事会 | 微型铁调素肽及其使用方法 |
| WO2013112663A1 (en) * | 2012-01-26 | 2013-08-01 | The Johns Hopkins University | Myonectin (ctrp15), compositions comprising same, and methods of use |
-
2013
- 2013-10-31 AU AU2013337808A patent/AU2013337808B2/en not_active Ceased
- 2013-10-31 RU RU2015120601A patent/RU2684216C2/ru active
- 2013-10-31 KR KR1020157013416A patent/KR102186218B1/ko not_active Expired - Fee Related
- 2013-10-31 JP JP2015540784A patent/JP6501362B2/ja not_active Expired - Fee Related
- 2013-10-31 CN CN201380065041.2A patent/CN104854130A/zh active Pending
- 2013-10-31 WO PCT/US2013/067771 patent/WO2014071015A1/en not_active Ceased
- 2013-10-31 BR BR112015009954A patent/BR112015009954A2/pt not_active Application Discontinuation
- 2013-10-31 CA CA2890040A patent/CA2890040A1/en not_active Abandoned
- 2013-10-31 ES ES13851277T patent/ES2731609T3/es active Active
- 2013-10-31 EP EP13851277.7A patent/EP2914619B1/en not_active Not-in-force
-
2015
- 2015-04-28 US US14/698,608 patent/US20160122409A1/en not_active Abandoned
-
2018
- 2018-06-01 US US15/996,152 patent/US20180355008A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015536337A5 (https=) | ||
| JP2013539454A5 (https=) | ||
| CN111757878A (zh) | 一种哒嗪类衍生物抑制剂、其制备方法和应用 | |
| JP2017507181A5 (https=) | ||
| WO2015073580A8 (en) | Tumor necrosis factor-like ligand 1a specific antibodies and compositions and uses thereof | |
| WO2015024668A3 (en) | Respiratory syncytial virus (rsv) vaccine | |
| JP2014533700A5 (https=) | ||
| EP2324113A4 (en) | VIRUS LIKE PARTICLES WITH COMPOUND CAPSIDAMINOIC ACID SEQUENCES FOR INCREASED CROSS-REACTIVITY | |
| HK1212711A1 (zh) | Bcma抗原結合蛋白 | |
| CN112004801A (zh) | 一种c-MET 抑制剂的晶型及其盐型和制备方法 | |
| JP2017048194A5 (https=) | ||
| JP2016503793A5 (https=) | ||
| JP2014051497A5 (https=) | ||
| JP2010524466A5 (https=) | ||
| JP2016514159A5 (https=) | ||
| JP2012517818A5 (https=) | ||
| JP2009511579A5 (https=) | ||
| MX2012000765A (es) | Dominios variables sencillos de union de albumina anti-suero mejorados. | |
| JP2014528601A5 (https=) | ||
| JP2014094951A5 (https=) | ||
| BR112012026838A2 (pt) | terapias baseadas em ligante do recptor quimiossensorial | |
| CA2818990A1 (en) | Designed repeat proteins binding to serum albumin | |
| JP2011182796A5 (https=) | ||
| ME02177B (me) | Supstituisani derivati ksantina | |
| JP2017533237A5 (https=) |